Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Changes in Fungal Mycobiome, Bacterial Microbiome, and Abundance of Staphylococcus Species After Lebrikizumab Treatment - a Prospective Multicenter Observational Cohort Study

NCT07807228 is registered in ClinicalTrials.gov with University Hospital Bispebjerg and Frederiksberg as lead sponsor.

NCT NCT07807228
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07807228 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Changes in Fungal Mycobiome, Bacterial Microbiome, and Abundance of Staphylococcus Species After Lebrikizumab Treatment - a Prospective Multicenter Observational Cohort Study
Lead sponsor
University Hospital Bispebjerg and Frederiksberg
Phase
Observational
Overall status
Recruiting
Start date
June 5, 2025
Completion date
May 31, 2028
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atopic dermatitis